Research ArticleArticle
Clinical and Serological Analysis of Patients with Positive Anticyclic Citrullinated Peptide Antibodies Referred Through a Rheumatology Central Triage System
Liam Martin, Whitney A. Steber, Terri L. Lupton, Michael Mahler, Christie M. Fitch, Jacob D. McMillan, Danielle R. Schmidt and Marvin J. Fritzler
The Journal of Rheumatology February 2015, jrheum.141054; DOI: https://doi.org/10.3899/jrheum.141054
Liam Martin
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Whitney A. Steber
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Terri L. Lupton
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Michael Mahler
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Christie M. Fitch
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Jacob D. McMillan
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Danielle R. Schmidt
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
Marvin J. Fritzler
From the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Inova Diagnostics Inc., San Diego, California, USA. Funded and supported by resources from Mitogen Advanced Diagnostics Laboratory, as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology in the Cumming School of Medicine at the University of Calgary. M. Fritzler is a paid consultant and has received honoraria or gifts in kind from Inova Diagnostics. L. Martin, MB, MRCPI, FRCPC, Professor of Medicine; W.A. Steber, BPE, BSc, Clinical Research Manager; T.L. Lupton, RN, Clinical Coordinator; C.M. Fitch, RN; J.D. McMillan, Research Assistant; D.R. Schmidt, Research Assistant; M.J. Fritzler, PhD, MD, FRCPC, Professor of Medicine, Faculty of Medicine, University of Calgary; M. Mahler, PhD, Vice-President, Research and Development, Inova Diagnostics Inc. Address correspondence to Dr. M.J. Fritzler, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada. E-mail: fritzler@ucalgary.ca. Accepted for publication December 12, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical and Serological Analysis of Patients with Positive Anticyclic Citrullinated Peptide Antibodies Referred Through a Rheumatology Central Triage System
Liam Martin, Whitney A. Steber, Terri L. Lupton, Michael Mahler, Christie M. Fitch, Jacob D. McMillan, Danielle R. Schmidt, Marvin J. Fritzler
The Journal of Rheumatology Feb 2015, jrheum.141054; DOI: 10.3899/jrheum.141054
Clinical and Serological Analysis of Patients with Positive Anticyclic Citrullinated Peptide Antibodies Referred Through a Rheumatology Central Triage System
Liam Martin, Whitney A. Steber, Terri L. Lupton, Michael Mahler, Christie M. Fitch, Jacob D. McMillan, Danielle R. Schmidt, Marvin J. Fritzler
The Journal of Rheumatology Feb 2015, jrheum.141054; DOI: 10.3899/jrheum.141054